Breadcrumb

Banner - Infectious Diseases and Immunity in Global Health Program -IDIGH

IDIGH  |  Infectious Diseases and Immunity in Global Health Program

IDIGH News heading

News

Asset Publisher

Containment Level 3 facilities advance COVID-19 research at the RI-MUHC and McGill

Infrastructure to study COVID-19 in a secure environment is creating new possibilities for collaboration and discovery

From silent infection to rapid death: Why are some people more vulnerable to COVID-19?

Scientists discover genetic and immunological causes of 15 percent of life-threatening COVID-19 cases

New study of therapy options in metastatic melanoma

RI-MUHC researchers lead “real-world” analysis of treatment patterns with checkpoint inhibitors

Lashanda Skerritt awarded Vanier Canada Graduate Scholarship

“I am constantly reminded that community involvement and advocacy are important drivers of scientific and medical knowledge,” says the RI-MUHC trainee

Inappropriate prescriptions sending hospitalized seniors back to the ER

Improving hospital prescribing practices may reduce risk of rehospitalization and death

Early treatment trial of hydroxychloroquine shows no symptomatic benefit for COVID-19 patients

Adult outpatients with mild symptoms of COVID-19 don’t benefit from taking hydroxychloroquine

A good showing for the IDIGH Program in 2020-2021 FRQS awards

Congratulations to researchers and trainees!

Recipient of the 2020-2021 Dr. Margaret Becklake Fellowship: Mikashmi Kohli

A postdoctoral fellow from the RI-MUHC is recognized for international work on TB diagnostics

Three COVID-19 projects at the RI-MUHC to receive CIHR funding

A $109M fund aims to mitigate impact of the pandemic on care delivery in Canada and beyond, as well as contribute to better understanding of the disease

COVID-19 pandemic: Looking back to better tackle future challenges

In two recent studies, RI-MUHC researchers provide useful information for evaluating public health strategies

Innovation Moves Online for the 2020 McGill Clinical Innovation Competition

RI-MUHC research team, Emily McDonald and Todd C. Lee, ties for Marika Zelenka Roy Innovation Prize

COVID-19 impact on cancer patients: MUHC researchers take part in a multinational study

Published in The Lancet, the study reveals cancer-specific factors associated with increased mortality

Hydroxychloroquine not effective in preventing the development of COVID-19 when used as post-exposure prophylaxis

A new study suggests that hydroxychloroquine is not effective in preventing the development of COVID-19 in individuals exposed to SARS-CoV-2

Results of MI4 Emergency COVID-19 Research Funding (Round 2)

RI-MUHC researchers awarded MUHC Foundation funding for a second round of projects with potential impact in a short timeframe

Looking to produce a COVID-19 vaccine in the greenhouse

RI-MUHC researcher working with Quebec-based company on a plant-based technique

We Care About Rare!

Researchers, advocates and patients gather on Rare Disease Research Day at the RI-MUHC

RI-MUHC researchers review diagnostic tests for COVID-19

Study published in the Annals of Internal Medicine

Results of MI4 Emergency COVID-19 Research Funding (Round 1)

RI-MUHC researchers awarded MUHC Foundation funding for projects with potential impact in a short timeframe

FRQ to create a province-wide COVID-19 Biobank

RI-MUHC researchers take leading roles in the initiative

See Archive - IDIGH